ORASURE TECHNOLOGIES, INC Repayments of Long-Term Debt
ORASURE TECHNOLOGIES, INC (OSUR) reported Repayments of Long-Term Debt of $7.29 million for the 12-month period ending 2012-12-31, per its 10-K filed 2015-03-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2015-03-12
- ORASURE TECHNOLOGIES, INC repayments of long-term debt for the quarter ending 2012-12-31 was $0.00, a 100.00% decline year-over-year.
- ORASURE TECHNOLOGIES, INC repayments of long-term debt for the quarter ending 2012-09-30 was $7.04M, a 5533.60% increase year-over-year.
- ORASURE TECHNOLOGIES, INC repayments of long-term debt for the quarter ending 2012-06-30 was $125.00K, a 0.00% change year-over-year.
- ORASURE TECHNOLOGIES, INC repayments of long-term debt for the quarter ending 2012-03-31 was $125.00K, a 0.00% change year-over-year.
- ORASURE TECHNOLOGIES, INC repayments of long-term debt for fiscal 2012 was $7.29M, a 1358.40% increase from fiscal 2011.
- ORASURE TECHNOLOGIES, INC repayments of long-term debt for fiscal 2011 was $500.00K, a 1.96% decline from fiscal 2010.
- ORASURE TECHNOLOGIES, INC repayments of long-term debt for fiscal 2010 was $510.00K, a 8.59% decline from fiscal 2009.
- ORASURE TECHNOLOGIES, INC repayments of long-term debt for fiscal 2009 was $557.90K.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 9 month as first filed | Repayments of Long-term Debt 12 month | Repayments of Long-term Debt 12 month as first filed |
|---|---|---|---|---|---|---|
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $7.04M derived: sum of 2 quarters · filed 2015-03-12 | $7.17M derived: sum of 3 quarters · filed 2015-03-12 | $7.29M 10-K · filed 2015-03-12 | ||
| 2012-09-30 | $7.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $7.17M derived: sum of 2 quarters · filed 2013-11-07 | $7.29M 10-Q · filed 2013-11-07 | $7.29M 10-Q · filed 2012-11-09 | $7.42M derived: sum of 4 quarters · filed 2014-03-14 | |
| 2012-06-30 | $125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $250.00K 10-Q · filed 2013-08-08 | $375.00K derived: sum of 3 quarters · filed 2014-03-14 | $500.00K derived: sum of 4 quarters · filed 2014-03-14 | ||
| 2012-03-31 | $125.00K 10-Q · filed 2013-05-09 | $250.00K derived: sum of 2 quarters · filed 2014-03-14 | $375.00K derived: sum of 3 quarters · filed 2014-03-14 | $500.00K derived: sum of 4 quarters · filed 2014-03-14 | ||
| 2011-12-31 | $125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $250.00K derived: sum of 2 quarters · filed 2014-03-14 | $375.00K derived: sum of 3 quarters · filed 2014-03-14 | $500.00K 10-K · filed 2014-03-14 | ||
| 2011-09-30 | $125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $250.00K derived: sum of 2 quarters · filed 2012-11-09 | $375.00K 10-Q · filed 2012-11-09 | $500.24K derived: sum of 4 quarters · filed 2013-03-13 | ||
| 2011-06-30 | $125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $250.00K 10-Q · filed 2012-08-08 | $375.24K derived: sum of 3 quarters · filed 2013-03-13 | $500.24K derived: sum of 4 quarters · filed 2013-03-13 | ||
| 2011-03-31 | $125.00K 10-Q · filed 2012-05-09 | $250.24K derived: sum of 2 quarters · filed 2013-03-13 | $375.24K derived: sum of 3 quarters · filed 2013-03-13 | |||
| 2010-12-31 | $125.24K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-13 | $250.24K derived: sum of 2 quarters · filed 2013-03-13 | $510.00K 10-K · filed 2013-03-13 | $509.76K 10-K · filed 2012-03-14 | ||
| 2010-09-30 | $125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $384.76K 10-Q · filed 2011-11-09 | ||||
| 2010-06-30 | $259.76K 10-Q · filed 2011-08-05 | |||||
| 2009-12-31 | $557.90K 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |